bèta
Trial Radar AI
De klinische studie NCT07259954 voor Prediabetes is nog niet rekruterend. Bekijk de kaartweergave van de Klinische Studies Radar en de AI-ontdekkingstools voor alle details. Of stel hier een vraag.
Eén studie komt overeen met de filtercriteria
Kaartweergave
Terug naar zoekresultaten

Prediabetes and Metabolic Parameters Among Young Adults at Assiut University Hospital

Nog niet rekruterend
Informatie over klinische studies is voornamelijk in het Engels beschikbaar. Trial Radar AI kan echter helpen! Klik op 'Leg studie uit' om de informatie over de studie te bekijken en te bespreken in de taal van uw keuze.
De klinische studie NCT07259954 is een observationeel studie bij Prediabetes met de status nog niet rekruterend. De inclusie van 120 deelnemers start op 1 december 2025. De studie wordt geleid door de Universiteit van Assioet en de voltooiing is gepland op 1 februari 2028. Laatste update op ClinicalTrials.gov: 2 december 2025.
Beknopte samenvatting
Prediabetes is a major public health problem that increases the risk of developing type 2 diabetes mellitus and cardiovascular complications. Young adults represent an important age group in which early detection and intervention may prevent progression of the disease. The present study aims to identify factors associated with prediabetes and metabolic complications, and classify individuals based on clinical and biochemical profiles according to insulin resistance, dyslipidemia and fatty liver. This is an observational, cross-sectional study that will be conducted at Assiut University Hospital. Data will be collected through clinical examination, laboratory investigations, and assessment of metabolic profiles.
Officiële titel

Prediabetes Among Young Adults and Its Relation to Metabolic Parameters in Persons Attending Assuit University Hospital

Aandoeningen
Prediabetes
Publicaties
Wetenschappelijke artikelen en onderzoekspapers gepubliceerd over deze klinische studie:
  • http://doi.org/10.1007/s00125-013-2902-4
  • http://doi.org/10.1136/bmj.g4485
  • http://doi.org/10.1007/s00125-009-1443-3
  • http://doi.org/10.2337/dc08-1264
  • http://doi.org/10.1016/j.diabres.2007.05.004
  • http://doi.org/10.2337/diabetes.52.6.1475
  • http://doi.org/10.1136/bmj.i5953
  • http://doi.org/10.1056/NEJMoa012512
  • http://doi.org/10.1016/S0140-6736(12)60525-X
  • http://doi.org/10.2337/dc10-0679
  • http://doi.org/10.2337/diacare.2951130
  • http://doi.org/10.2337/dc07-9920
  • http://doi.org/10.1016/S0140-6736(12)60283-9
  • International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: IDF; 2021. http://www.diabetesatlas.org
Andere studie-ID's
  • AUH-MED-PREDIAB-2025
NCT-ID
NCT07259954
Startdatum (Werkelijk)
2025-12-01
Laatste update geplaatst
2025-12-02
Verwachte einddatum
2028-02-01
Inschrijving (Geschat)
120
Studietype
Observationeel
Status
Nog niet rekruterend
Trefwoorden
Predabetes
Armen / Interventies
Deelnemersgroep/StudiearmInterventie/Behandeling
Group A impaired glucose tolerance_Group B - Impaired Fasting Glucose Group C - Impaired HbA1c
GEEN INTERVENTIE
Participants will be classified into groups based on impaired fasting glucose, impaired post-prandial glucose, or impaired HbA1c according to ADA criteria
Primaire uitkomst
UitkomstmaatBeschrijving van de uitkomstmaatTijdsbestek
Correlation between prediabetes subtypes and metabolic syndrome
Primary Outcome Title: Correlation between prediabetes phenotypes and metabolic syndrome Outcome Measure: Prevalence (%) of metabolic syndrome within each prediabetes phenotype (IFG, IGT, combined IFG/IGT, elevated HbA1c). Description: Metabolic syndrome will be assessed at baseline according to the IDF definition. Participants will be classified into prediabetes phenotypes, and the proportion of individuals meeting metabolic syndrome criteria within each phenotype will be recorded. Time Frame: Baseline Unit of Measure: Percentage (%)
At baseline (cross-sectional assessment during enrollment).
Secundaire uitkomst
UitkomstmaatBeschrijving van de uitkomstmaatTijdsbestek
Factors affecting the correlation between prediabetes phenotypes and metabolic abnormalities (age, gender, family history, body physique, waist circumference and physical activity.
Secondary Outcome 1 Title: Age Description: Participant age in years. Unit of Measure: Years Time Frame: Baseline Secondary Outcome 2 Title: Sex Description: Participant sex as recorded at baseline. Unit of Measure: Categorical Time Frame: Baseline Secondary Outcome 3 Title: Family history of diabetes Description: Presence of family history of diabetes in first-degree relatives. Unit of Measure: Yes/No Time Frame: Baseline Secondary Outcome 4 Title: Weight Description: Body weight measured using a calibrated scale. Unit of Measure: Kilograms Time Frame: Baseline Secondary Outcome 5 Title: Height Description: Participant height measured using a stadiometer. Unit of Measure: Centimeters Time Frame: Baseline Secondary Outcome 6 Title: Body Mass Index (BMI) Description: BMI calculated as weight (kg) divided by height squared (m²). Unit of Measure: kg/m² Time Frame: Baseline Secondary Outcome 7 Title: Waist circumference Description: Waist circumference measured using a non-stretchab
At baseline (cross-sectional assessment during enrollment)
Geschiktheidscriteria

Leeftijd van deelnemers
Volwassene
Minimumleeftijd
18 Years
Geslachten die in aanmerking komen voor de studie
Allen
Accepteert gezonde vrijwilligers
Ja
  • adults diagnosed with prediabetes

  • previous diagnosis of overt diabetes
  • other causes of CKD (e.g. urinary tract infection)
  • other causes of liver disease (e.g. HBV infection),
  • use of medications that alter glucose or lipid metabolism (e.g. corticosteroids),
  • current pregnancy
Assiut University logoUniversiteit van Assioet1413 actieve klinische studies om te verkennen
Verantwoordelijke instantie
Heba Gamal Ali Mohamed, Hoofdonderzoeker, Internal medicine ,assuit university hospital, Assiut University
Geen contactgegevens beschikbaar